481

Compound name
Orelabrutinib
Alt Name
ICP-022
ICP022
Compound Image
Orelabrutinib.png
SMILES
C=CC(=O)N1CCC(CC1)C2=NC(=C(C=C2)C(=O)N)C3=CC=C(C=C3)OC4=CC=CC=C4
MW
427.50
Brutto
C26H25N3O3
InChI
InChI=1S/C26H25N3O3/c1-2-24(30)29-16-14-18(15-17-29)23-13-12-22(26(27)31)25(28-23)19-8-10-21(11-9-19)32-20-6-4-3-5-7-20/h2-13,18H,1,14-17H2,(H2,27,31)
InChI Key
MZPVEMOYADUARK-UHFFFAOYSA-N
Approval Jurisdiction
2020 China
Approved for clinical use
Mantle Cell Lymphoma CLL, SLL
CAS
1655504-04-3
PubChem CID
91667513
Action
BTK
Approved Drug List
1
Commercial Vendor
InnoCare